Journals / Turkish Journal of Rheumatology(.)Archives of Rheumatology / 2009 / Cilt: 24 - Sayı: 1

Succesful treatment of intermittant hydrartrosis with colchicine: A case report

İntermittan hidrartrozun kolşisinle başarılı tedavisi: Olgu sunumu

Pages
58–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case is of interest since to our knowledge there have been only two patients reported in the literature with remission of IH achieved by colchicine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intermittent hydrarthrosis (IH) is a monoarticular disease of unknown etiology, characterized by episodic effusions, and it usually affects middle-aged women.
📊
Key Findings & Data:Here, we report a 37-year-old female with IH in whom successful remission was obtained with colchicine treatment.
💡
Conclusion & Impact:This case is of interest since to our knowledge there have been only two patients reported in the literature with remission of IH achieved by colchicine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kolşisin · Hidrartoz · Tedavi sonucu

Abstract

Intermittent hydrarthrosis (IH) is a monoarticular disease of unknown etiology, characterized by episodic effusions, and it usually affects middle-aged women. Acute phase reactants are within normal range during attacks. Although this non-destructive disease has no definite treatment, non-steroidal anti-inflammatory drugs, intraarticular steroids, and radioactive and surgical synovectomy have been used. Here, we report a 37-year-old female with IH in whom successful remission was obtained with colchicine treatment. This case is of interest since to our knowledge there have been only two patients reported in the literature with remission of IH achieved by colchicine.

Özet

İntermittan hidrartroz (İH), sebebi bilinmeyen, genelde orta yaş kadınları etkileyen, tek eklemi tutan, epizodik efüzyonlarla karakterize bir hastalıktır. Ataklar sırasında akut faz reaktanları normal sınırlardadır. Destrüktif olmayan hastalığın tam tedavisi olmamakla beraber, steroid olmayan antiinflamauar ilaçlar, eklem içi steroid enjeksiyonu, radyoaktif ya da cerrahi sinovektomi denenebilir. Literatürde kolşisine yanıt veren sadece iki İH hastası tanımlandığından biz, kolşisine kısmi yanıt veren 37 yaşında İH'lu bayan hastayı sunmak istedik.

🔖

Cite This Article

ADAM, M., YILDIZ, Z., CİVELEK, G. M., LEBLEBİCİ, B. (2009). Succesful treatment of intermittant hydrartrosis with colchicine: A case report. Turkish Journal of Rheumatology(.)Archives of Rheumatology, Cilt: 24 - Sayı: 1, 58–59. https://ajindex.com/articles/376064

References (6)

  1. Kastner DL, Aksentijevich I. Intermittent and periodic arthritis syndromes. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1411-61
  2. Queiro-Silva R, Tinture-Eguren T, Lopez-Lagunas I. Successful therapy with low-dose colchicine in intermittent hydrarthrosis. Rheumatology 2003; 42: 391-2
  3. Albert DA, Schumacher HR. Miscellaneous arthropathies. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology Philadelphia:Mosby; 2008: 1659-69 4. Cañete JD, Aróstegui JI, Queiró R, Sanmartí R, Ballina J, Bosch X, Yagüe J. Association of intermittent hydrarthrosis with MEFV gene mutations. Arthritis Rheum. 2006; 54: 2334-5
  4. Querio R, Canete J, Arostegui JI, Yague J. May some cases of intermittent hydrarthrosis represent an atypical form of calcium pyrophosphate dihldrate crystal deposition diease? Usefulness of mutational analysis of the MEFV gene. Semin Arthritis Rheum 2008; 37: 269-70
  5. Sanmarti R, Canete JD, Salvador G. Palindromic rheumatism and other relapsing arthritis. Best Pract Res Clin Rheumatol 2004;18: 647-61
  6. Terkeltaub RA. Pathogenesis and treatment of crystalinduced inflamation. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions. Philadelphia: Lippincott Williams & Wilkins; 2005; p. 2357-72.